The Board of Directors of Cannara Biotech Inc. has authorized a buyback plan on November 11, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.81 CAD | +3.85% | +9.46% | -2.41% |
1st Jan change | Capi. | |
---|---|---|
-2.41% | 51.39M | |
-.--% | 339M | |
+35.05% | 277M | |
+45.93% | 182M | |
+156.53% | 145M | |
-35.62% | 137M | |
+43.74% | 136M | |
-42.86% | 121M | |
+15.38% | 80.3M | |
+10.00% | 60.26M |
- Stock Market
- Equities
- LOVE Stock
- News Cannara Biotech Inc.
- Cannara Biotech Inc. authorizes a Buyback Plan.